Lista de obras - Ross TS - Dominio Público Uruguay

Aberrant Huntingtin interacting protein 1 in lymphoid malignancies

scientific article published on 01 September 2007

Altered receptor trafficking in Huntingtin Interacting Protein 1-transformed cells.

artículo científico publicado en 2003

An internal performance assessment of CancerGene Connect: an electronic tool to streamline, measure and improve the genetic counseling process.

artículo científico publicado en 2014

Analysis of induced pluripotent stem cells from a BRCA1 mutant family

artículo científico publicado en 2013

Clathrin- and AP-2-binding sites in HIP1 uncover a general assembly role for endocytic accessory proteins

artículo científico publicado en 2001

Cloning and expression of human 75-kDa inositol polyphosphate-5-phosphatase

scientific journal article

Cyclic hydrolase-transfected 3T3 cells have low levels of inositol 1,2-cyclic phosphate and reach confluence at low density ⬇️

artículo científico publicado el 15 de mayo de 1991

Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated with Estrogen Receptor-Negative Subtypes and Poor Prognosis.

artículo científico publicado en 2015

Deficiency of the Endocytic Protein Hip1 Leads to Decreased Gdpd3 Expression, Low Phosphocholine, and Kypholordosis.

artículo científico publicado en 2018

Degenerative phenotypes caused by the combined deficiency of murine HIP1 and HIP1r are rescued by human HIP1.

artículo científico publicado en 2007

Democratization of genetic data: connecting government approval of clinical tests with data sharing.

artículo científico publicado en 2015

Distinct Brca1 Mutations Differentially Reduce Hematopoietic Stem Cell Function

artículo científico publicado en 2017

Expression of BCR/ABL p210 from a knockin allele enhances bone marrow engraftment without inducing neoplasia

artículo científico publicado en 2013

Family still matters: Counseling patients with complex family histories of colon and endometrial cancers

artículo científico publicado en 2019

Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2).

artículo científico publicado en 1998

Genetic Counseling Assistants: an Integral Piece of the Evolving Genetic Counseling Service Delivery Model.

artículo científico publicado en 2016

Grace Rock's consent

artículo científico publicado en 2012

HIP1: trafficking roles and regulation of tumorigenesis.

artículo científico publicado en 2004

Hip1-related mutant mice grow and develop normally but have accelerated spinal abnormalities and dwarfism in the absence of HIP1.

artículo científico publicado en 2004

Hip1r is expressed in gastric parietal cells and is required for tubulovesicle formation and cell survival in mice

scientific journal article

Huntingtin interacting protein 1 Is a clathrin coat binding protein required for differentiation of late spermatogenic progenitors

artículo científico publicado en 2001

Huntingtin interacting protein 1 is a novel brain tumor marker that associates with epidermal growth factor receptor.

artículo científico publicado en 2007

Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptors

artículo científico publicado en 2005

Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival

artículo científico publicado en 2002

Huntingtin-interacting protein 1 phosphorylation by receptor tyrosine kinases.

artículo científico publicado en 2013

Huntingtin-interacting protein 1: a Merkel cell carcinoma marker that interacts with c-Kit.

artículo científico publicado en 2011

Identification of a phosphodiesterase that converts inositol cyclic 1:2-phosphate to inositol 2-phosphate.

artículo científico publicado en 1992

Inositol-1,2-cyclic-phosphate 2-inositolphosphohydrolase. Substrate specificity and regulation of activity by phospholipids, metal ion chelators, and inositol 2-phosphate ⬇️

artículo científico publicado el 15 de enero de 1991

Isolation of D-myo-inositol 1:2-cyclic phosphate 2-inositolphosphohydrolase from human placenta

artículo científico publicado en 1986

Metabolic gatekeeper function of B-lymphoid transcription factors

artículo científico publicado en 2017

Prediction of Cancer Prevention: From Mammogram Screening to Identification of BRCA1/2 Mutation Carriers in Underserved Populations

artículo científico publicado en 2015

Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing

artículo científico publicado en 2018

Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia

artículo científico publicado en 2014

Serum antibodies to huntingtin interacting protein-1: a new blood test for prostate cancer

artículo científico publicado en 2005

The metabolism of phosphoinositide-derived messenger molecules.

artículo científico publicado en 1986

Toward a therapeutic reduction of imatinib refractory myeloproliferative neoplasm-initiating cells

artículo científico publicado en 2013

Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes ⬇️

artículo científico publicado el 15 de septiembre de 1998

Transforming properties of the Huntingtin interacting protein 1/ platelet-derived growth factor beta receptor fusion protein.

artículo científico publicado en 1999

Use of Whole Genome Sequencing for Diagnosis and Discovery in the Cancer Genetics Clinic.

artículo científico publicado en 2015

Use of a cryptic splice site for the expression of huntingtin interacting protein 1 in select normal and neoplastic tissues

artículo científico publicado en 2008

Use of panel tests in place of single gene tests in the cancer genetics clinic.

artículo científico publicado en 2014

Lista de obras de Ross TS

Aberrant Huntingtin interacting protein 1 in lymphoid malignancies

Altered receptor trafficking in Huntingtin Interacting Protein 1-transformed cells.

An internal performance assessment of CancerGene Connect: an electronic tool to streamline, measure and improve the genetic counseling process.

Analysis of induced pluripotent stem cells from a BRCA1 mutant family

Clathrin- and AP-2-binding sites in HIP1 uncover a general assembly role for endocytic accessory proteins

Cloning and expression of human 75-kDa inositol polyphosphate-5-phosphatase

Cyclic hydrolase-transfected 3T3 cells have low levels of inositol 1,2-cyclic phosphate and reach confluence at low density ⬇️

Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated with Estrogen Receptor-Negative Subtypes and Poor Prognosis.

Deficiency of the Endocytic Protein Hip1 Leads to Decreased Gdpd3 Expression, Low Phosphocholine, and Kypholordosis.

Degenerative phenotypes caused by the combined deficiency of murine HIP1 and HIP1r are rescued by human HIP1.

Democratization of genetic data: connecting government approval of clinical tests with data sharing.

Distinct Brca1 Mutations Differentially Reduce Hematopoietic Stem Cell Function

Expression of BCR/ABL p210 from a knockin allele enhances bone marrow engraftment without inducing neoplasia

Family still matters: Counseling patients with complex family histories of colon and endometrial cancers

Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2).

Genetic Counseling Assistants: an Integral Piece of the Evolving Genetic Counseling Service Delivery Model.

Grace Rock's consent

HIP1: trafficking roles and regulation of tumorigenesis.

Hip1-related mutant mice grow and develop normally but have accelerated spinal abnormalities and dwarfism in the absence of HIP1.

Hip1r is expressed in gastric parietal cells and is required for tubulovesicle formation and cell survival in mice

Huntingtin interacting protein 1 Is a clathrin coat binding protein required for differentiation of late spermatogenic progenitors

Huntingtin interacting protein 1 is a novel brain tumor marker that associates with epidermal growth factor receptor.

Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptors

Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival

Huntingtin-interacting protein 1 phosphorylation by receptor tyrosine kinases.

Huntingtin-interacting protein 1: a Merkel cell carcinoma marker that interacts with c-Kit.

Identification of a phosphodiesterase that converts inositol cyclic 1:2-phosphate to inositol 2-phosphate.

Inositol-1,2-cyclic-phosphate 2-inositolphosphohydrolase. Substrate specificity and regulation of activity by phospholipids, metal ion chelators, and inositol 2-phosphate ⬇️

Isolation of D-myo-inositol 1:2-cyclic phosphate 2-inositolphosphohydrolase from human placenta

Metabolic gatekeeper function of B-lymphoid transcription factors

Prediction of Cancer Prevention: From Mammogram Screening to Identification of BRCA1/2 Mutation Carriers in Underserved Populations

Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing

Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia

Serum antibodies to huntingtin interacting protein-1: a new blood test for prostate cancer

The metabolism of phosphoinositide-derived messenger molecules.

Toward a therapeutic reduction of imatinib refractory myeloproliferative neoplasm-initiating cells

Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes ⬇️

Transforming properties of the Huntingtin interacting protein 1/ platelet-derived growth factor beta receptor fusion protein.

Use of Whole Genome Sequencing for Diagnosis and Discovery in the Cancer Genetics Clinic.

Use of a cryptic splice site for the expression of huntingtin interacting protein 1 in select normal and neoplastic tissues

Use of panel tests in place of single gene tests in the cancer genetics clinic.